A recent case study, reported in Case Reports in Urology, presented an unusual case of a patient with metastatic renal cell carcinoma (RCC) and brain metastases who experienced a complete response to cabozantinib prior to radiation therapy.

This case study contributes to the limited evidence on the activity of cabozantinib within the brain. The researchers suggest that further investigation is needed to look at the ability of cabozantinib to cross the blood-brain barrier and cause a clinical response.

Read the case study in Case Reports in Urology here